1-3 of 3
Limin Xing, PhD
Close
Sort by
Journal Articles

Histone Deacetylase 6 (HDAC6) As a Regulator of Immune Check-Point Molecules in Chronic Lymphocytic Leukemia (CLL)

John J. Powers, B.S., Kamira K. Maharaj, B.S., Eva Sahakian, PhD, Limin Xing, PhD, Patricio PerezVillarroel, BS, Tessa Knox, MS, Steven Quayle, Simon S Jones, PhD, Alejandro Villagra, PhD, Eduardo M. Sotomayor, MD, Javier Pinilla-Ibarz, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3311.
https://doi.org/10.1182/blood.V124.21.3311.3311
Published: 2014
Journal Articles

Histone Deacetylase 11 (HDAC11) As a Novel Transcriptional Regulator of C/EBP-β, in Immature Myeloid Cell to Myeloid Derived Suppressor Cell Transition

Jie Chen, MA, Eva Sahakian, PhD, John J. Powers, B.S., Maritza LienlafMoreno, BS, Limin Xing, PhD, Susan Deng, Allison Distler, Fengdong Cheng, MD, Alejandro Villagra, PhD, Pedro Horna, MD, Eduardo M. Sotomayor, MD, Javier Pinilla-Ibarz, MD PhD
Journal: Blood
Blood (2014) 124 (21): 225.
https://doi.org/10.1182/blood.V124.21.225.225
Published: 2014
Journal Articles

Efficacy and Safety of Monoclonal Anti-CD20 Antibody Rituximab Combined Cyclophosphamide in Treatment of Refractory and Recurrent Autoimmune Hemolytic Anemia

Zonghong Shao, MD, Hong Liu, PhD, Limin Xing, PhD, Yuhong Wu, MD, Wen Qu, MD, Yong Liang, PhD, Jing Guan, MD, Guojin Wang, MD, Xiaoming Wang, MD, Jia Song, PhD, Lijuan Li, PhD, Huaquan Wang, PhD
Journal: Blood
Blood (2012) 120 (21): 5161.
https://doi.org/10.1182/blood.V120.21.5161.5161
Published: 2012